Skip to content

EMEUNEWS

Search
  • Congress Topics
    • Basic Research
    • Imaging
    • Metabolic and Crystal Arthropathies
    • Paediatric Rheumatology
    • Rare and Autoinflammatory Diseases
    • Rheumatoid Arthritis I – Clinical (non-therapeutic)
    • Rheumatoid arthritis II – therapeutic
    • Spondyloarthritis I – non-therapeutic
    • Spondyloarthritis II – therapeutic
  • Featured Content
  • Press Review
    • Annals of the Rheumatic Diseases
    • RMD Open
    • Arthritis and Rheumatology
    • Rheumatology (Oxford)
    • Arthritis Research and Therapy
    • Arthritis Care and Research
    • Seminars in Arthritis and Rheumatism
    • The Lancet Rheumatology
    • Miscellaneous
  • About EMEUNEWS
  • About EMEUNET
  • Contact Us
  • Subscribe here!

Category: Press Review

Arthritis Care and Research…

Autumn 2025 Press Review – Arthritis Care and Research

22 Sep 202529 Sep 2025
April 2025 to July 2025 Author: Antony Psarras Risk of Incident Heart Failure and Heart Failure Subtypes in Patients With Rheumatoid Arthritis Kawano et al. (10.1002/acr.25481) identified incident HF and categorized…
Arthritis and Rheumatology…

Autumn 2025 Press Review – Arthritis & Rheumatology

22 Sep 202529 Sep 2025
April 2025 to July 2025 Author: Antony Psarras Neutrophil Activation Markers and Rheumatoid Arthritis Treatment Response to the JAK1/2 Inhibitor Baricitinib Kuley et al. (10.1002/art.43042) analysed markers of neutrophil activation,…
Press Review…

Autumn 2025 Press Review – Arthritis Research & Therapy

22 Sep 202529 Sep 2025
April 2025 to July 2025 Author: Clementina López-Medina Real-world data on the use of the Shingrix vaccine among patients with inflammatory arthritis and risk of cardiovascular events following herpes zoster Curtis…
Press Review…

Autumn 2025 Press Review – The Lancet Rheumatology

22 Sep 202529 Sep 2025
April 2025 to July 2025 Author: Clementina López-Medina Baricitinib in early polymyalgia rheumatic (BACHELOR): a randomised, double-blind, placebo-controlled, parallel group trial Saraux A, et al. (10.1016/S2665-9913(24)00270-4) aimed to test whether baricitinib…
Miscellaneous…

Autumn 2025 Press Review – Miscellanous

22 Sep 202529 Sep 2025
April 2025 to July 2025 Author: Victoria Konzett Upadacitinib FDA and EMA-approved for treatment of giant cell arteritis after positive results from the SELECT-GCA study Blockmans et al. (10.1056/NEJMoa2413449) compared Upadacitinib…
Press Review…

Autumn 2025 Press Review – Rheumatology (Oxford)

22 Sep 202529 Sep 2025
April 2025 to July 2025 Author: Jacob J.E. Koopman ‘Am I doing this right?’ Physician perceptions of the global assessment in clinical trials of systemic sclerosis Sabanovic and colleagues (10.1093/rheumatology/keaf377) interviewed…
Press Review…

Autumn 2025 Press Review – RMD Open

22 Sep 202529 Sep 2025
April 2025 to July 2025 Author: Omar Dhrif Long-term maintenance of remission with spacing of rituximab infusions based on the individualised patient risk profile in ANCA-associated vasculitis: a pilot study Bartoletti…
Press Review…

Autumn 2025 Press Review – Seminars in Arthritis and Rheumatism

22 Sep 202529 Sep 2025
April 2025 to July 2025 Author: Jacob J.E. Koopman Current evidence on switching between biologic therapies for Still’s disease: a systematic literature review Dagna and colleagues (10.1016/j.semarthrit.2025.152789) studied publications about the…
Annals of the Rheumatic Diseases…

Spring 2025 Press Review – Annals of Rheumatic Diseases

12 May 202512 May 2025
December 2024 to March 2025 Author: Victoria Konzett & Mustafa Ekici Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with different classes of biologics Gisondi P, et al.…
Arthritis Care and Research…

Spring2025 Press Review – Arthritis Care & Research

12 May 2025
December 2024 to March 2025 Author:  Rym Abida & Clementina Lopez-Medina Analysis of the longitudinal behaviour of serum levels of angiogenic markers in pregnant women with Systemic Lupus Erythematosus De…

Posts navigation

Older posts
Newer posts

Seestrasse 240
CH 8802 Kilchberg (ZH)
Switzerland
emeunet@eular.ch
emeunet.eular.org

About EULAR
The European Alliance of Associations for Rheumatology, EULAR, is the organisation which represents the people with arthritis/rheumatism, health professionals in rheumatology (HPR) and scientific societies of rheumatology of all the European nations.
Visit website here

About EMEUNET
EMEUNET is an exciting community that started its activities in 2009, emanating from one of the objectives set by EULAR – "Bring on board high quality, young generation contributors in all EULAR activities".
Visit website here

  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • Spotify
 

Loading Comments...